When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MTFB - Motif Bio granted meeting with regarding iclaprim; shares up 57% premarket
Motif Bio plc
The FDA has granted Motif Bio's (NASDAQ:MTFB) request for a Type A meeting to discuss the points raised in the Complete Response Letter related to the NDA for iclaprim for the treatment of acute bacterial skin and skin structure infections.
More news on: Motif Bio plc, Motif Bio plc, Healthcare stocks news, Stocks on the move,